NOVARTIS, ALNYLAM JOIN HANDS FOR NEW FLU TREATMENT

Pharmaceutical companies Novartis AG and Alnylam Pharmaceuticals Tuesday announced that they have joined hands to develop a new flu treatment, using a gene level therapy developed by the latter.

Newratings (http://www.newratings.com/analyst_news/article_1211443.html)